Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TAO Synergies (TAOX) Cash & Equivalents (2019 - 2026)

TAO Synergies filings provide 8 years of Cash & Equivalents readings, the most recent being $3.6 million for Q1 2026.

  • Quarterly Cash & Equivalents fell 75.37% to $3.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $3.6 million through Mar 2026, down 75.37% year-over-year, with the annual reading at $5.5 million for FY2025, 68.86% down from the prior year.
  • Cash & Equivalents hit $3.6 million in Q1 2026 for TAO Synergies, down from $5.5 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $37.5 million in Q4 2022 and bottomed at $3.6 million in Q1 2026.
  • Average Cash & Equivalents over 5 years is $23.7 million, with a median of $26.3 million recorded in 2022.
  • The largest annual shift saw Cash & Equivalents surged 110.8% in 2022 before it tumbled 75.37% in 2026.
  • TAO Synergies' Cash & Equivalents stood at $37.5 million in 2022, then fell by 23.53% to $28.7 million in 2023, then tumbled by 38.4% to $17.7 million in 2024, then crashed by 68.86% to $5.5 million in 2025, then tumbled by 33.68% to $3.6 million in 2026.
  • Per Business Quant, the three most recent readings for TAOX's Cash & Equivalents are $3.6 million (Q1 2026), $5.5 million (Q4 2025), and $14.4 million (Q2 2025).